These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38577085)

  • 21. Comprehensive Analysis of the Prognostic Signature of Mutation-Derived Genome Instability-Related lncRNAs for Patients With Endometrial Cancer.
    Liu J; Cui G; Ye J; Wang Y; Wang C; Bai J
    Front Cell Dev Biol; 2022; 10():753957. PubMed ID: 35433686
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma.
    Zhu J; Huang Q; Peng X; Luo C; Liu S; Liu Z; Wu X; Luo H
    Front Oncol; 2022; 12():799475. PubMed ID: 35433487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.
    Wang X; Qian J; Yao N; Pocha C; Kang KJ; Angelico R; Zhu G
    Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome instability-related LINC02577, LINC01133 and AC107464.2 are lncRNA prognostic markers correlated with immune microenvironment in pancreatic adenocarcinoma.
    Zhang Y; Wang Y; He X; Yao R; Fan L; Zhao L; Lu B; Pang Z
    BMC Cancer; 2023 May; 23(1):430. PubMed ID: 37173624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
    Huang EM; Ma N; Ma T; Zhou JY; Yang WS; Liu CX; Hou ZH; Chen S; Zong Z; Zeng B; Li YR; Zhou TC
    World J Gastrointest Oncol; 2022 Oct; 14(10):1981-2003. PubMed ID: 36310708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Validation of a Mutational Burden-Associated LncRNA Signature for Improving the Clinical Outcome of Hepatocellular Carcinoma.
    Xu M; Ma T; Shi S; Xing J; Xi Y
    Life (Basel); 2021 Nov; 11(12):. PubMed ID: 34947843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma.
    Tang X; Miao Y; Wang J; Cai T; Yang L; Mi D
    Comput Math Methods Med; 2021; 2021():1205029. PubMed ID: 34840594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer.
    Bao S; Zhao H; Yuan J; Fan D; Zhang Z; Su J; Zhou M
    Brief Bioinform; 2020 Sep; 21(5):1742-1755. PubMed ID: 31665214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a genomic instability-related lncRNA prognostic model for hepatocellular carcinoma.
    Xun Z; Wang Y; Long J; Li Y; Yang X; Sun H; Zhao H
    Front Genet; 2022; 13():1034979. PubMed ID: 36712850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a Somatic Mutation-Derived Long Non-Coding RNA Signatures of Genomic Instability in Renal Cell Carcinoma.
    Fang X; Liu X; Lu L; Liu G
    Front Oncol; 2021; 11():728181. PubMed ID: 34676164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of somatic mutator-derived and immune infiltrates related lncRNA signatures of genome instability reveals potential prognostic biomarkers involved in non-small cell lung cancer.
    Yang CZ; Yang T; Liu XT; He CF; Guo W; Liu S; Yao XH; Xiao X; Zeng WR; Lin LZ; Huang ZY
    Front Genet; 2022; 13():982030. PubMed ID: 36226174
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic instability-related lncRNA prognostic signature.
    Jing L; Du Y; Fu D
    Front Genet; 2022; 13():979575. PubMed ID: 36105083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma.
    Zhang Z; Zhang W; Wang Y; Wan T; Hu B; Li C; Ge X; Lu S
    Front Cell Dev Biol; 2022; 10():792676. PubMed ID: 35295858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients.
    Huang S; Li D; Zhuang L; Zhang J; Wu J
    Front Med (Lausanne); 2022; 9():850343. PubMed ID: 35685422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A computational prognostic model of lncRNA signature for clear cell renal cell carcinoma with genome instability.
    Cui T; Guo J; Sun Z
    Expert Rev Mol Diagn; 2022 Feb; 22(2):213-222. PubMed ID: 34871123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The development and validation of a novel senescence-related long-chain non-coding RNA (lncRNA) signature that predicts prognosis and the tumor microenvironment of patients with hepatocellular carcinoma.
    Huang E; Ma T; Zhou J; Ma N; Yang W; Liu C; Hou Z; Chen S; de Castria TB; Zeng B; Zong Z; Zhou T
    Ann Transl Med; 2022 Jul; 10(14):766. PubMed ID: 35965795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis.
    Wang X; Zhang H; Ye J; Gao M; Jiang Q; Zhao T; Wang S; Mao W; Wang K; Wang Q; Chen X; Hou X; Han D
    Front Genet; 2022; 13():850888. PubMed ID: 35571034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a Genomic Instability-Related Long Noncoding RNA Prognostic Model in Colorectal Cancer Based on Bioinformatic Analysis.
    Liang Y; Sun HX; Ma B; Meng QK
    Dis Markers; 2022; 2022():4556585. PubMed ID: 35711569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.